Use of atropine methonitrate (0.1 mg) orally for NIDDM.
Shah
Ramesh C
RC
D000284:Administration, Oral; D001286:Atropine Derivatives / Q000008:administration & dosage / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*
D001286:Atropine Derivatives; D010276:Parasympatholytics; C006649:methylatropine